Plasma concentrations and pharmacokinetics of idebenone and its metabolites following single and repeated doses in young patients with mitochondrial encephalomyopathy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1996-10

AUTHORS

P. Pisano, A. Durand, E. Autret, C. Desnuelle, N. Pinsard, G. Serratrice, V. Legout, M. Joubert, O. Blin

ABSTRACT

Objective: The pharmacokinetics and tolerance of idebenone after single or repeated doses have been studied in young patients with mitochondrial encephalomyopathy.Results:No significant adverse effects were noted. In 3 out of 7 patients idebenone induced overall stimulation and improvement in arousal. Plasma concentrations of idebenone and its main metabolites were determined and the pharmacokinetic parameters of idebenone after single and repeated doses were estimated. During the single dose study, the mean plasma concentrations of idebenone and its main metabolites and mean pharmacokinetic parameters were comparable to published results (Cmax = 452.2 ng ⋅ ml−1, tmax = 2.3 h, AUC = 26 μg ⋅ ml−1 ⋅ h, t1/2β = 16.5 h). During the repeated doses study, no significant difference was found between mean residual plasma concentrations of idebenone on Day 2 (47 ng ⋅ ml−1) and Day 5 (70.6 ng ⋅ ml−1), and mean t1/2β of idebenone after the single and after repeated dose studies, i.e., there was no evidence of accumulation. Although idebenone did not appear to accumulate during this study, the coadministration of anticonvulsants, often prescribed during mitochondrial encephalomyopathy, can affect its pharmacokinetics. More... »

PAGES

167-169

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002280050179

DOI

http://dx.doi.org/10.1007/s002280050179

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1034477311

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8911883


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anticonvulsants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzoquinones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitochondrial Encephalomyopathies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenobarbital", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ubiquinone", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Laboratoire de Pharmacocin\u00e9tique et Toxicocin\u00e9tique, CHU Timone, 254 rue St Pierre, F-133855 Marseille Cedex 5, France, FR", 
          "id": "http://www.grid.ac/institutes/grid.411266.6", 
          "name": [
            "Laboratoire de Pharmacocin\u00e9tique et Toxicocin\u00e9tique, CHU Timone, 254 rue St Pierre, F-133855 Marseille Cedex 5, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pisano", 
        "givenName": "P.", 
        "id": "sg:person.0736647653.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736647653.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratoire de Pharmacocin\u00e9tique et Toxicocin\u00e9tique, CHU Timone, 254 rue St Pierre, F-133855 Marseille Cedex 5, France, FR", 
          "id": "http://www.grid.ac/institutes/grid.411266.6", 
          "name": [
            "Laboratoire de Pharmacocin\u00e9tique et Toxicocin\u00e9tique, CHU Timone, 254 rue St Pierre, F-133855 Marseille Cedex 5, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Durand", 
        "givenName": "A.", 
        "id": "sg:person.01076774661.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076774661.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratoire de Pharmacologie, H\u00f4pital Bretonneau, F-37044 Tours, France, FR", 
          "id": "http://www.grid.ac/institutes/grid.411777.3", 
          "name": [
            "Laboratoire de Pharmacologie, H\u00f4pital Bretonneau, F-37044 Tours, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Autret", 
        "givenName": "E.", 
        "id": "sg:person.01233433262.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233433262.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de Neurologie, Laboratoire de Neurobiologie Cellulaire, H\u00f4pital Pasteur, BP 69, F-06002 Nice, France, FR", 
          "id": "http://www.grid.ac/institutes/grid.464719.9", 
          "name": [
            "Service de Neurologie, Laboratoire de Neurobiologie Cellulaire, H\u00f4pital Pasteur, BP 69, F-06002 Nice, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Desnuelle", 
        "givenName": "C.", 
        "id": "sg:person.0641144447.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641144447.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de Neurologie P\u00e9diatrique, CHU Timone Enfants, F-13385 Marseille Cedex 5, France, FR", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Service de Neurologie P\u00e9diatrique, CHU Timone Enfants, F-13385 Marseille Cedex 5, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pinsard", 
        "givenName": "N.", 
        "id": "sg:person.01235116036.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235116036.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinique des Maladies du Syst\u00e8me Nerveux et de l\u2019Appareil Locomoteur, CHU Timone Adultes, F-13385 Marseille Cedex 5, France, FR", 
          "id": "http://www.grid.ac/institutes/grid.411266.6", 
          "name": [
            "Clinique des Maladies du Syst\u00e8me Nerveux et de l\u2019Appareil Locomoteur, CHU Timone Adultes, F-13385 Marseille Cedex 5, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Serratrice", 
        "givenName": "G.", 
        "id": "sg:person.01236731722.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236731722.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratoires Takeda, 15 Quai de Dion Bouton, F-92816 Puteaux Cedex, France, FR", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Laboratoires Takeda, 15 Quai de Dion Bouton, F-92816 Puteaux Cedex, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Legout", 
        "givenName": "V.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratoires Takeda, 15 Quai de Dion Bouton, F-92816 Puteaux Cedex, France, FR", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Laboratoires Takeda, 15 Quai de Dion Bouton, F-92816 Puteaux Cedex, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joubert", 
        "givenName": "M.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pharmacologie M\u00e9dicale et Clinique and Centre de Pharmacologie Clinique et d\u2019Evaluations Th\u00e9rapeutiques, CHU Timone Bt F-13385 Marseille Cedex 5, France, FR", 
          "id": "http://www.grid.ac/institutes/grid.411266.6", 
          "name": [
            "Pharmacologie M\u00e9dicale et Clinique and Centre de Pharmacologie Clinique et d\u2019Evaluations Th\u00e9rapeutiques, CHU Timone Bt F-13385 Marseille Cedex 5, France, FR"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blin", 
        "givenName": "O.", 
        "id": "sg:person.0655347463.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655347463.28"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1996-10", 
    "datePublishedReg": "1996-10-01", 
    "description": "Objective: The pharmacokinetics and tolerance of idebenone after single or repeated doses have been studied in young patients with mitochondrial encephalomyopathy.Results:No significant adverse effects were noted. In 3 out of 7 patients idebenone induced overall stimulation and improvement in arousal. Plasma concentrations of idebenone and its main metabolites were determined and the pharmacokinetic parameters of idebenone after single and repeated doses were estimated. During the single dose study, the mean plasma concentrations of idebenone and its main metabolites and mean pharmacokinetic parameters were comparable to published results (Cmax = 452.2 ng \u22c5 ml\u22121, tmax = 2.3\u2005h, AUC = 26\u2005\u03bcg\u2009\u22c5 ml\u22121\u2009\u22c5 h, t1/2\u03b2 = 16.5\u2005h). During the repeated doses study, no significant difference was found between mean residual plasma concentrations of idebenone on Day 2 (47\u2005ng \u22c5 ml\u22121) and Day 5 (70.6\u2005ng \u22c5 ml\u22121), and mean t1/2\u03b2 of idebenone after the single and after repeated dose studies, i.e., there was no evidence of accumulation. Although idebenone did not appear to accumulate during this study, the coadministration of anticonvulsants, often prescribed during mitochondrial encephalomyopathy, can affect its pharmacokinetics.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s002280050179", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "51"
      }
    ], 
    "keywords": [
      "plasma concentrations", 
      "younger patients", 
      "mitochondrial encephalomyopathy", 
      "dose study", 
      "pharmacokinetic parameters", 
      "pharmacokinetics of idebenone", 
      "mean plasma concentration", 
      "single dose study", 
      "residual plasma concentrations", 
      "main metabolite", 
      "significant adverse effects", 
      "evidence of accumulation", 
      "day 2", 
      "day 5", 
      "patients", 
      "adverse effects", 
      "pharmacokinetics", 
      "idebenone", 
      "doses", 
      "significant differences", 
      "encephalomyopathy", 
      "doses studies", 
      "overall stimulation", 
      "metabolites", 
      "coadministration", 
      "anticonvulsants", 
      "t1/2\u03b2", 
      "study", 
      "stimulation", 
      "concentration", 
      "arousal", 
      "evidence", 
      "differences", 
      "accumulation", 
      "tolerance", 
      "effect", 
      "improvement", 
      "results", 
      "parameters", 
      "tolerance of idebenone", 
      "mean residual plasma concentrations", 
      "t1/2\u03b2 of idebenone", 
      "coadministration of anticonvulsants"
    ], 
    "name": "Plasma concentrations and pharmacokinetics of idebenone and its metabolites following single and repeated doses in young patients with mitochondrial encephalomyopathy", 
    "pagination": "167-169", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034477311"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002280050179"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8911883"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002280050179", 
      "https://app.dimensions.ai/details/publication/pub.1034477311"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:10", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_293.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s002280050179"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002280050179'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002280050179'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002280050179'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002280050179'


 

This table displays all metadata directly associated to this object as RDF triples.

226 TRIPLES      21 PREDICATES      83 URIs      75 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002280050179 schema:about N009555d7c2584201b4e71098b074212b
2 N055b312ec3ef452c93f14872c39e5945
3 N076cdd6b386b401293dc3ab8205ac8d6
4 N2e7b15412ba140b787a0127def5e2bd1
5 N331c3dc5c76c4c8b96dc2a13b754cc12
6 N34e30c71f2e04869ab4232c72734282a
7 N680f65b7d254468dacbe8a36a54b5d3d
8 N841c4e0dbaed496ca4561d8804e15647
9 N8d0d7f8c9edf451ba7270f1f7b40cc5b
10 N92a4c8933d444af190434dfa744ad6a5
11 N92c71b91627842aba2b86ce80991144e
12 Nad1c6045bc7442ecbc9d7638b878c35a
13 Nec3ac44ed0a24f0abe7e3c396c93cb1b
14 anzsrc-for:11
15 anzsrc-for:1109
16 schema:author N462c7abf885345738e35e4a8ae219ec3
17 schema:datePublished 1996-10
18 schema:datePublishedReg 1996-10-01
19 schema:description Objective: The pharmacokinetics and tolerance of idebenone after single or repeated doses have been studied in young patients with mitochondrial encephalomyopathy.Results:No significant adverse effects were noted. In 3 out of 7 patients idebenone induced overall stimulation and improvement in arousal. Plasma concentrations of idebenone and its main metabolites were determined and the pharmacokinetic parameters of idebenone after single and repeated doses were estimated. During the single dose study, the mean plasma concentrations of idebenone and its main metabolites and mean pharmacokinetic parameters were comparable to published results (Cmax = 452.2 ng ⋅ ml−1, tmax = 2.3 h, AUC = 26 μg ⋅ ml−1 ⋅ h, t1/2β = 16.5 h). During the repeated doses study, no significant difference was found between mean residual plasma concentrations of idebenone on Day 2 (47 ng ⋅ ml−1) and Day 5 (70.6 ng ⋅ ml−1), and mean t1/2β of idebenone after the single and after repeated dose studies, i.e., there was no evidence of accumulation. Although idebenone did not appear to accumulate during this study, the coadministration of anticonvulsants, often prescribed during mitochondrial encephalomyopathy, can affect its pharmacokinetics.
20 schema:genre article
21 schema:inLanguage en
22 schema:isAccessibleForFree false
23 schema:isPartOf N57b2a5769b464a89b8754e829c67e624
24 N677f75ffae484a54a2a56f2c5b7cca7e
25 sg:journal.1054337
26 schema:keywords accumulation
27 adverse effects
28 anticonvulsants
29 arousal
30 coadministration
31 coadministration of anticonvulsants
32 concentration
33 day 2
34 day 5
35 differences
36 dose study
37 doses
38 doses studies
39 effect
40 encephalomyopathy
41 evidence
42 evidence of accumulation
43 idebenone
44 improvement
45 main metabolite
46 mean plasma concentration
47 mean residual plasma concentrations
48 metabolites
49 mitochondrial encephalomyopathy
50 overall stimulation
51 parameters
52 patients
53 pharmacokinetic parameters
54 pharmacokinetics
55 pharmacokinetics of idebenone
56 plasma concentrations
57 residual plasma concentrations
58 results
59 significant adverse effects
60 significant differences
61 single dose study
62 stimulation
63 study
64 t1/2β
65 t1/2β of idebenone
66 tolerance
67 tolerance of idebenone
68 younger patients
69 schema:name Plasma concentrations and pharmacokinetics of idebenone and its metabolites following single and repeated doses in young patients with mitochondrial encephalomyopathy
70 schema:pagination 167-169
71 schema:productId N456b5bed0f8943bd89b4b7b3f0aa0a5a
72 N7090282ef1a74920a96275b6e8c77ad9
73 N7f57b3b0dc1942c88423bdb40eb5f071
74 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034477311
75 https://doi.org/10.1007/s002280050179
76 schema:sdDatePublished 2021-12-01T19:10
77 schema:sdLicense https://scigraph.springernature.com/explorer/license/
78 schema:sdPublisher N12d15ec5f9ed4e82a6fd638acf040166
79 schema:url https://doi.org/10.1007/s002280050179
80 sgo:license sg:explorer/license/
81 sgo:sdDataset articles
82 rdf:type schema:ScholarlyArticle
83 N009555d7c2584201b4e71098b074212b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Child, Preschool
85 rdf:type schema:DefinedTerm
86 N055b312ec3ef452c93f14872c39e5945 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Drug Therapy, Combination
88 rdf:type schema:DefinedTerm
89 N076cdd6b386b401293dc3ab8205ac8d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Male
91 rdf:type schema:DefinedTerm
92 N0d83204db4564929a7ea64f8af0b5c61 schema:affiliation grid-institutes:None
93 schema:familyName Joubert
94 schema:givenName M.
95 rdf:type schema:Person
96 N12d15ec5f9ed4e82a6fd638acf040166 schema:name Springer Nature - SN SciGraph project
97 rdf:type schema:Organization
98 N213183720b2d4a72bfb7582fcaca8db4 rdf:first sg:person.01076774661.77
99 rdf:rest N503c39606d4e4ec8b09acfa0d72e2b3e
100 N2485c847ba0c460180c425cf81f946f3 rdf:first sg:person.01236731722.98
101 rdf:rest N547298c96cec4fc29365e1f04ba38e27
102 N2b38832a9da3468aaae130e011b83ab6 rdf:first sg:person.0655347463.28
103 rdf:rest rdf:nil
104 N2e7b15412ba140b787a0127def5e2bd1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Child
106 rdf:type schema:DefinedTerm
107 N331c3dc5c76c4c8b96dc2a13b754cc12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Female
109 rdf:type schema:DefinedTerm
110 N34e30c71f2e04869ab4232c72734282a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Adolescent
112 rdf:type schema:DefinedTerm
113 N3735d649752e47a1a66176876bebdace schema:affiliation grid-institutes:None
114 schema:familyName Legout
115 schema:givenName V.
116 rdf:type schema:Person
117 N456b5bed0f8943bd89b4b7b3f0aa0a5a schema:name pubmed_id
118 schema:value 8911883
119 rdf:type schema:PropertyValue
120 N462c7abf885345738e35e4a8ae219ec3 rdf:first sg:person.0736647653.09
121 rdf:rest N213183720b2d4a72bfb7582fcaca8db4
122 N503c39606d4e4ec8b09acfa0d72e2b3e rdf:first sg:person.01233433262.98
123 rdf:rest Nff1f19f0bc9844a2bd8bc007f369455a
124 N547298c96cec4fc29365e1f04ba38e27 rdf:first N3735d649752e47a1a66176876bebdace
125 rdf:rest Nc50b7c3e0a8d4d3fbdef02451a9d6d49
126 N57b2a5769b464a89b8754e829c67e624 schema:volumeNumber 51
127 rdf:type schema:PublicationVolume
128 N677f75ffae484a54a2a56f2c5b7cca7e schema:issueNumber 2
129 rdf:type schema:PublicationIssue
130 N680f65b7d254468dacbe8a36a54b5d3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Mitochondrial Encephalomyopathies
132 rdf:type schema:DefinedTerm
133 N7090282ef1a74920a96275b6e8c77ad9 schema:name doi
134 schema:value 10.1007/s002280050179
135 rdf:type schema:PropertyValue
136 N73eb0339cafa4701a761e50283ab30b7 rdf:first sg:person.01235116036.93
137 rdf:rest N2485c847ba0c460180c425cf81f946f3
138 N7f57b3b0dc1942c88423bdb40eb5f071 schema:name dimensions_id
139 schema:value pub.1034477311
140 rdf:type schema:PropertyValue
141 N841c4e0dbaed496ca4561d8804e15647 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Humans
143 rdf:type schema:DefinedTerm
144 N8d0d7f8c9edf451ba7270f1f7b40cc5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Anticonvulsants
146 rdf:type schema:DefinedTerm
147 N92a4c8933d444af190434dfa744ad6a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Ubiquinone
149 rdf:type schema:DefinedTerm
150 N92c71b91627842aba2b86ce80991144e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Phenobarbital
152 rdf:type schema:DefinedTerm
153 Nad1c6045bc7442ecbc9d7638b878c35a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Drug Administration Schedule
155 rdf:type schema:DefinedTerm
156 Nc50b7c3e0a8d4d3fbdef02451a9d6d49 rdf:first N0d83204db4564929a7ea64f8af0b5c61
157 rdf:rest N2b38832a9da3468aaae130e011b83ab6
158 Nec3ac44ed0a24f0abe7e3c396c93cb1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Benzoquinones
160 rdf:type schema:DefinedTerm
161 Nff1f19f0bc9844a2bd8bc007f369455a rdf:first sg:person.0641144447.05
162 rdf:rest N73eb0339cafa4701a761e50283ab30b7
163 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
164 schema:name Medical and Health Sciences
165 rdf:type schema:DefinedTerm
166 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
167 schema:name Neurosciences
168 rdf:type schema:DefinedTerm
169 sg:journal.1054337 schema:issn 0031-6970
170 1432-1041
171 schema:name European Journal of Clinical Pharmacology
172 schema:publisher Springer Nature
173 rdf:type schema:Periodical
174 sg:person.01076774661.77 schema:affiliation grid-institutes:grid.411266.6
175 schema:familyName Durand
176 schema:givenName A.
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076774661.77
178 rdf:type schema:Person
179 sg:person.01233433262.98 schema:affiliation grid-institutes:grid.411777.3
180 schema:familyName Autret
181 schema:givenName E.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233433262.98
183 rdf:type schema:Person
184 sg:person.01235116036.93 schema:affiliation grid-institutes:None
185 schema:familyName Pinsard
186 schema:givenName N.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235116036.93
188 rdf:type schema:Person
189 sg:person.01236731722.98 schema:affiliation grid-institutes:grid.411266.6
190 schema:familyName Serratrice
191 schema:givenName G.
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236731722.98
193 rdf:type schema:Person
194 sg:person.0641144447.05 schema:affiliation grid-institutes:grid.464719.9
195 schema:familyName Desnuelle
196 schema:givenName C.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641144447.05
198 rdf:type schema:Person
199 sg:person.0655347463.28 schema:affiliation grid-institutes:grid.411266.6
200 schema:familyName Blin
201 schema:givenName O.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655347463.28
203 rdf:type schema:Person
204 sg:person.0736647653.09 schema:affiliation grid-institutes:grid.411266.6
205 schema:familyName Pisano
206 schema:givenName P.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736647653.09
208 rdf:type schema:Person
209 grid-institutes:None schema:alternateName Laboratoires Takeda, 15 Quai de Dion Bouton, F-92816 Puteaux Cedex, France, FR
210 Service de Neurologie Pédiatrique, CHU Timone Enfants, F-13385 Marseille Cedex 5, France, FR
211 schema:name Laboratoires Takeda, 15 Quai de Dion Bouton, F-92816 Puteaux Cedex, France, FR
212 Service de Neurologie Pédiatrique, CHU Timone Enfants, F-13385 Marseille Cedex 5, France, FR
213 rdf:type schema:Organization
214 grid-institutes:grid.411266.6 schema:alternateName Clinique des Maladies du Système Nerveux et de l’Appareil Locomoteur, CHU Timone Adultes, F-13385 Marseille Cedex 5, France, FR
215 Laboratoire de Pharmacocinétique et Toxicocinétique, CHU Timone, 254 rue St Pierre, F-133855 Marseille Cedex 5, France, FR
216 Pharmacologie Médicale et Clinique and Centre de Pharmacologie Clinique et d’Evaluations Thérapeutiques, CHU Timone Bt F-13385 Marseille Cedex 5, France, FR
217 schema:name Clinique des Maladies du Système Nerveux et de l’Appareil Locomoteur, CHU Timone Adultes, F-13385 Marseille Cedex 5, France, FR
218 Laboratoire de Pharmacocinétique et Toxicocinétique, CHU Timone, 254 rue St Pierre, F-133855 Marseille Cedex 5, France, FR
219 Pharmacologie Médicale et Clinique and Centre de Pharmacologie Clinique et d’Evaluations Thérapeutiques, CHU Timone Bt F-13385 Marseille Cedex 5, France, FR
220 rdf:type schema:Organization
221 grid-institutes:grid.411777.3 schema:alternateName Laboratoire de Pharmacologie, Hôpital Bretonneau, F-37044 Tours, France, FR
222 schema:name Laboratoire de Pharmacologie, Hôpital Bretonneau, F-37044 Tours, France, FR
223 rdf:type schema:Organization
224 grid-institutes:grid.464719.9 schema:alternateName Service de Neurologie, Laboratoire de Neurobiologie Cellulaire, Hôpital Pasteur, BP 69, F-06002 Nice, France, FR
225 schema:name Service de Neurologie, Laboratoire de Neurobiologie Cellulaire, Hôpital Pasteur, BP 69, F-06002 Nice, France, FR
226 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...